The role of P2Y6 receptor in the pathogenesis of cardiovascular and inflammatory diseases

J Pharmacol Sci. 2024 Feb;154(2):108-112. doi: 10.1016/j.jphs.2024.01.003. Epub 2024 Jan 5.

Abstract

The purinergic receptor P2Y6 receptor (P2Y6R) is a member of the G protein-coupled receptors (GPCR) family. P2Y6R is widely expressed in various cell types and plays a critical role in physiological processes, where it is activated by extracellular uridine diphosphate (UDP) and mobilizes Ca2+ via the Gαq/11 protein pathway. We have recently discovered the pathophysiological role of P2Y6R in cardiovascular and inflammatory diseases, including inflammatory bowel disease and non-alcoholic fatty liver disease. Furthermore, we uncovered the redox-dependent internalization of P2Y6R. In this review, we provide a comprehensive overview of the pathophysiological activity of P2Y6R in cardiovascular and inflammatory diseases. Additionally, we discuss the concept of atypical internalization control of GPCRs, which may be applied in the prevention and treatment of intestinal inflammation and cardiovascular remodeling.

Keywords: Cardiovascular disease; G protein-coupled receptors; Inflammation; Internalization; Non-alcoholic steatohepatitis.

Publication types

  • Review

MeSH terms

  • Cardiovascular System*
  • Humans
  • Inflammatory Bowel Diseases*
  • Non-alcoholic Fatty Liver Disease*
  • Receptors, Purinergic P2*

Substances

  • purinoceptor P2Y6
  • Receptors, Purinergic P2